CRISIS
BUSINESS
0%, 100%, then 200%: How Trump's new generic drug tariff plan could hit India
Donald Trump announced phased tariffs on imported generic medicines starting August 2026. These tariffs will gradually increase to 200 percent over three years. This policy aims to reshore pharmaceutical production back into America. India,
Read the original at Times of India ↗Also reported by 5 other newsrooms
NDTV BusinessThreat Or Opportunity? How Trump's Generic Drug Tariff Plan Could Impact Indian Pharma StocksFree Press JournalUS President Donald Trump Announces Up To 200% Tariffs On Imported Generic Medicines, Threatening India's $9.7 Billion Pharma Exports ToHindustan Times0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicinesNDTVTrump Announces Upto 200% Tariffs On Generic Drugs, Move May Impact IndiaLivemintAnother setback to India? Trump says US may impose tariffs upto 200% on generic drug imports. Here's why